Pancreatic cancer detection with a non-contrast MR protocol: is it reliable?

PURPOSE: The pancreatic cancer (PC) is the 4th leading cancer-related death, becoming the second one by 2030, with a 5 year survival rate of 8%. Considering its increased incidence in high-risk categories compared to the general population, we aimed to validate a non-contrast MR protocol, to detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Maio, Francesca, Pasqualino, Vincenzo, Bertana, Luca, Venturini, Silvia, Cantoni, Valeria, Fusaro, Michele, Morana, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Abdominal Radiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474201/
https://www.ncbi.nlm.nih.gov/pubmed/37515631
http://dx.doi.org/10.1007/s11547-023-01680-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474201/
https://www.ncbi.nlm.nih.gov/pubmed/37515631
http://dx.doi.org/10.1007/s11547-023-01680-z

Ejemplares similares